News Releases

All of the latest news about our university. (by topic)

UB professor’s book inspires new digital exhibition
12/3/21
Cecil Foster’s “They Call Me George: The Untold Story of Black Train Porters and the Birth of Modern Canada” is the focus of an in-depth multimedia exhibition at the Myseum of Toronto.
Study: Older MS patients who discontinue medications experience worsening of their disease
12/2/21
A new study provides evidence that discontinuing medications in older and previously stable MS patients results in new disease worsening/progression.
Study: How to freeze-dry a potential COVID-19 vaccine
12/1/21
In Science Advances, scientists report successfully freeze-drying specialized liposomes that could be developed for use in future vaccines.
Two UB faculty receive NSF funding to study social media in disaster response
11/29/21
The interdisciplinary project will focus on how Twitter users describe their locations during disasters.
Study says humpback whale song is about finding, not attracting, whales
11/29/21
UB researcher says his latest paper is another strike against the idea that whales sing to attract mates; findings indicate that whales echolocate, like dolphins and bats.
How sugar-loving microbes could help power future cars
11/22/21
In a new study, genetically engineered E. coli eat glucose, then help turn it into molecules found in gasoline.
Inhaled steroid keeps COVID-19 patients with mild to moderate disease out of the hospital
11/22/21
A national study has found that patients with mild to moderate COVID-19 who are treated with an inhaled steroid are significantly less likely to require emergency department care or hospitalization due to COVID-19 than those treated with placebo.
Tesluk will step down as dean
11/22/21
Under his leadership, the school has consistently ranked in the top 10% nationally across various major school and MBA rankings.
UB researchers discover how a top-ranking risk gene for autism spectrum disorders causes seizures
11/19/21
Researchers have revealed the biological mechanisms behind a key risk gene that plays a role in a number of brain diseases, including autism spectrum disorder.
Nearly 20 years on, no adverse impacts for pediatric cancer patients treated with dexrazoxane
11/19/21
A new study demonstrates that a drug administered to pediatric cancer patients in order to curb the cardiotoxicity of a key chemotherapy drug has no adverse impacts on these patients even 18 years later.

Next> <Previous